Brady James Aloysius

Track

Insider profile

Brady James Aloysius's trades of Xeris Biopharma Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
472.83
Quantity 70,132
Value US$3,185,605
Transaction date
Sale
Price
270.60
Quantity 59,052 +42.0%
Value US$2,636,770
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-01 2026-03-30
PlS Planned sale
21,651 -35.5%
481.62
US$2,483,875 		21,651 -35.5% 481.62 US$2,483,875
2026-03-30 2026-03-30
PrS Proposed sale
70,132
472.83
US$3,185,605 		70,132 472.83 US$3,185,605
2025-08-05 2025-08-01
S Sale
59,052 +42.0%
270.60
US$2,636,770 		59,052 +42.0% 270.60 US$2,636,770